Developing a Next-Generation Vaccine That Drives (A) More Durable and Broad Anti-Spike Neutralizing Antibodies (nabs) Against Variants of Concern (vocs), Including Those NOT Included in the Vaccine, and (B) T Cells Reactive Against Conserved Targets
Contract Overview
Contract Amount: $9,856,008 ($9.9M)
Contractor: Gritstone BIO, Inc.
Awarding Agency: Department of Health and Human Services
Start Date: 2023-09-25
End Date: 2025-03-31
Contract Duration: 553 days
Daily Burn Rate: $17.8K/day
Official Description: DEVELOPING A NEXT-GENERATION VACCINE THAT DRIVES (A) MORE DURABLE AND BROAD ANTI-SPIKE NEUTRALIZING ANTIBODIES (NABS) AGAINST VARIANTS OF CONCERN (VOCS), INCLUDING THOSE NOT INCLUDED IN THE VACCINE, AND (B) T CELLS REACTIVE AGAINST CONSERVED TARGETS
Place of Performance
Location: Massachusetts, 02215